Harbin Pharmaceutical Group Overview
- Founded
-
1989

- Status
-
Public
- Employees
-
3,179

- Stock Symbol
-
600829

- Investments
-
4
- Share Price
-
$0.96
- (As of Friday Closing)
Harbin Pharmaceutical Group General Information
Description
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
SHG
Primary Office
- Number 109 Xue Fu Road
- Harbin City, Nangang District 150086
- China
+86 0451 0000 0000
Harbin Pharmaceutical Group Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.96 | $0.95 | $0.77 - $1.32 | $557M | 580M | 18.1M | $0.06 |
Harbin Pharmaceutical Group Financials Summary
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 510,320 | 716,143 | 689,612 | 571,010 |
Revenue | 1,424,243 | 1,442,639 | 1,158,737 | 1,209,019 |
EBITDA | 53,989 | 71,769 | 39,025 | 59,186 |
Net Income | 35,809 | 42,945 | 21,026 | 38,690 |
Total Assets | 1,040,398 | 1,058,658 | 929,116 | 795,858 |
Total Debt | 187,326 | 208,276 | 104,956 | 74,891 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Harbin Pharmaceutical Group Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Harbin Pharmaceutical Group Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engag
Pharmaceuticals
Harbin City, China
3,179
As of 2021
000000 - 000
Harbin Pharmaceutical Group Competitors (6)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Daewoong Pharmaceutical Company | Corporation | Seoul, South Korea | 0000 | |||
0000000 000000000 | Corporation | Incheon, South Korea | 0000 | 00.000 | 00000000 | 00.000 |
0000-0 00000 00000 | Corporate Backed or Acquired | Seoul, South Korea | 00 | 000000000 | ||
00000000 00000 | Corporation | Mumbai, India | 00 | 00.000 | 00000000000 | 00.000 |
000000 00000000000 | Corporation | Tokyo, Japan | 00000 | 00000000 |
Harbin Pharmaceutical Group Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Haiying Xu | General Manager & Director | ||
Bo Liu | Deputy General Manager, Chief Accounting Officer & Director |
Harbin Pharmaceutical Group Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
00000 000 | Self | Board Member | 000 0000 |
Harbin Pharmaceutical Group Signals
Harbin Pharmaceutical Group Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Harbin Pharmaceutical Group Investments & Acquisitions (4)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 00000 | 07-Aug-2020 | 0000000000 | 00000 | Other Consumer Non-Durables | |
0000000 00000 | 13-Feb-2019 | 00000 0000 | Distributors/Wholesale | ||
0000000 00000 | 13-Feb-2019 | 0000 | 00000 | Other Consumer Non-Durables | 00000 000 |
Pfizer(swine vaccine business) | 31-May-2010 | Merger/Acquisition | 0000 | Drug Delivery |
Harbin Pharmaceutical Group Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
0000000 000000000 | Other Consumer Non-Durables | Pittsburgh, PA | 0000 |